Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome-Reference-Cited by-同舟云学术

Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome

Published:2010 Issue: Volume: Page:n/a-n/a
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenat. Diagn.

Author:

Huang Tianhua,Hoffman Barry,Meschino Wendy,Kingdom John,Okun Nanette

Publisher

Wiley

Subject

Genetics(clinical),Obstetrics and Gynaecology

Reference36 articles.

1. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes;Chandra;Am J Obstet Gynecol,2003

2. Double-positive maternal serum screening results for Down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes;Chitayat;Am J Obstet Gynecol,2002

3. Maternal serum inhibin A can predict preeclampsia;Cuckle;Br J Obstet Gynaecol,1998

4. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?;D'Anna;Acta Obstet Gynecol Scand,2002

5. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of preeclampsia;Davidson;BJOG,2003

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancies with ‘double-positive’ multiple marker screening results: a population-based study in Ontario, Canada;BMC Pregnancy and Childbirth;2024-09-06

2. Usefulness of early morphological ultrasound in association with cell-free DNA testing in case of atypical serum markers in first trimester of pregnancy: A retrospective study over 5 years;Journal of Gynecology Obstetrics and Human Reproduction;2024-04

3. The association between human chorionic gonadotropin and adverse pregnancy outcomes: a systematic review and meta-analysis;American Journal of Obstetrics and Gynecology;2024-02

4. Maternal First-Trimester Alpha-Fetoprotein and Placenta-Mediated Pregnancy Complications;Hypertension;2023-11

5. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies;Journal of Obstetrics and Gynaecology Canada;2023-10